All In MedTech

Device Trial Radar · NCT03719885

TrueTear in Sjogren's Disease Patients

Prospective Controlled Study of Intranasal Tear Neurostimulation for Sjogrens Patients With Dry Eye Disease

Last checked: Nov 20, 2026Latest source record: Jul 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

55

Actual

Start

Dec 1, 2018

Primary completion

Apr 25, 2019

Study completion Dec 31, 2019

Sponsor

Lead sponsor
University of PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Allergan
First posted
Oct 25, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate acute tear production produced by the intranasal tear neurostimulator in participants with Sjögrens syndrome and aqueous tear deficiency. Our primary goal is to evaluate whether Sjögrens patients respond to this intervention and whether there is a baseline tear production level below which these patients do not respond.

Conditions

  • Dry Eye Syndromes
  • Sjogren's Syndrome

Interventions

  • TrueTear Intranasal Tear NeurostimulatorDevice

    This study will evaluate the immediate tear production resulting from use of intranasal tear neurostimulation in patients with Sjogren's disease

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Schirmer TestingTime frame: Immediately following the procedure (ie immediately following use of the device)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Scheie Eye Institute, University of Pennsylvania

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.